References

Valencia IC, Falabella A, Kirsner RS, Eaglstein WH. Chronic venous insufficiency and venous leg ulceration. J Am Acad Dermatol. 2001; 44:(3)401-424 https://doi.org/10.1067/mjd.2001.111633

Sen CK, Gordillo GM, Roy S Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen. 2009; 17:(6)763-771 https://doi.org/10.1111/j.1524-475X.2009.00543.x

Nussbaum SR, Carter MJ, Fife CE An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health. 2018; 21:(1)27-32 https://doi.org/10.1016/j.jval.2017.07.007

Stockl K, Vanderplas A, Tafesse E, Chang E. Costs of lower-extremity ulcers among patients with diabetes. Diabetes Care. 2004; 27:(9)2129-2134 https://doi.org/10.2337/diacare.27.9.2129

Wound infection in clinical practice.: Wounds International; 2016

Edwards R, Harding KG. Bacteria and wound healing. Curr Opin Infect Dis. 2004; 17:(2)91-96 https://doi.org/10.1097/00001432-200404000-00004

Xu L, McLennan SV, Lo L Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care. 2007; 30:(2)378-380 https://doi.org/10.2337/dc06-1383

Maddocks SE. Microbial communities within the chronic wound. Microbiology Today. 2017; 70-73

Halim AS, Khoo TL, Mat Saad AZ. Wound bed preparation from a clinical perspective. Indian J Plast Surg. 2012; 45:(02)193-202 https://doi.org/10.4103/0970-0358.101277

Panuncialman J, Falanga V. The science of wound bed preparation. Surg Clin North Am. 2009; 89:(3)611-626 https://doi.org/10.1016/j.suc.2009.03.009

Leaper DJ, Schultz G, Carville K Extending the TIME concept: what have we learned in the past 10 years?. Int Wound J. 2012; 9:1-19 https://doi.org/10.1111/j.1742-481x.2012.01097.x

Reddy M, Gill SS, Wu W Does this patient have an infection of a chronic wound?. JAMA. 2012; 307:(6)605-611 https://doi.org/10.1001/jama.2012.98

Rennie MY, Lindvere-Teene L, Tapang K, Linden R. Point-of-care fluorescence imaging predicts the presence of pathogenic bacteria in wounds: a clinical study. J Wound Care. 2017; 26:(8)452-460 https://doi.org/10.12968/jowc.2017.26.8.452

Jones LM, Dunham D, Rennie MY In vitro detection of porphyrin-producing wound bacteria with real-time fluorescence imaging. Future Microbiol. 2020; 15:(5)319-332 https://doi.org/10.2217/fmb-2019-0279

Schalk IJ, Guillon L. Pyoverdine biosynthesis and secretion in Pseudomonas aeruginosa : implications for metal homeostasis. Environ Microbiol. 2013; 15:(6)1661-1673 https://doi.org/10.1111/1462-2920.12013

Serena TE, Harrell K, Serena L, Yaakov RA. Real-time bacterial fluorescence imaging accurately identifies wounds with moderate-to-heavy bacterial burden. J Wound Care. 2019; 28:(6)346-357 https://doi.org/10.12968/jowc.2019.28.6.346

Hurley CM, McClusky P, Sugrue RM Efficacy of a bacterial fluorescence imaging device in an outpatient wound care clinic: a pilot study. J Wound Care. 2019; 28:(7)438-443 https://doi.org/10.12968/jowc.2019.28.7.438

Rennie M, Dunham D, Lindvere-Teene L Understanding real-time fluorescence signals from bacteria and wound tissues observed with the MolecuLight i:XTM. Diagnostics (Basel). 2019; 9:(1) https://doi.org/10.3390/diagnostics9010022

Raizman R, Dunham D, Lindvere-Teene L Use of a bacterial fluorescence imaging device: wound measurement, bacterial detection and targeted debridement. J Wound Care. 2019; 28:(12)824-834 https://doi.org/10.12968/jowc.2019.28.12.824

Raizman R. Fluorescence imaging guided dressing change frequency during negative pressure wound therapy: a case series. J Wound Care. 2019; 28:S28-S37 https://doi.org/10.12968/jowc.2019.28.Sup9.S28

Hill R, Rennie M, Douglas J. Using bacterial fluorescence imaging and antimicrobial stewardship to guide wound management practices: a case series. Ostomy Wound Manage. 2018; 64:(8)18-28 https://doi.org/10.25270/owm.2018.8.1828

Hurley CM, McClusky P, Sugrue RM Efficacy of a bacterial fluorescence imaging device in an outpatient wound care clinic: a pilot study. J Wound Care. 2019; 28:(7)438-443 https://doi.org/10.12968/jowc.2019.28.7.438

How to use the MolecuLight i:X (e-Learning Modules). 2018;

Blackshaw EL, Jeffery SL. Efficacy of an imaging device at identifying the presence of bacteria in wounds at a plastic surgery outpatients clinic. J Wound Care. 2018; 27:(1)20-26 https://doi.org/10.1093/jbcr/irz167

Farhan N, Jeffery S. Utility of Moleculight i:X for managing bacterial burden in pediatric burns. J Burn Care Res. 2020; 41:(2)328-338

Avishai E, Yeghiazaryan K, Golubnitschaja O. Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J. 2017; 8:(1)23-33 https://doi.org/10.1007/s13167-017-0081-y

Schierle CF, De la Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 2009; 17:(3)354-359 https://doi.org/10.1111/j.1524-475X.2009.00489.x

Zhao G, Usui ML, Underwood RA Time course study of delayed wound healing in a biofilm-challenged diabetic mouse model. Wound Repair Regen. 2012; 20:(3)342-352 https://doi.org/10.1111/j.1524-475X.2012.00793.x

Robson MC, Heggers JP. Delayed wound closures based on bacterial counts. J Surg Oncol. 1970; 2:(4)379-383 https://doi.org/10.1002/jso.2930020410

Robson MC. Wound infection. A failure of wound healing caused by an imbalance of bacteria. Surg Clin North Am. 1997; 77:(3)637-650 https://doi.org/10.1016/S0039-6109(05)70572-7

Sheehan P, Jones P, Caselli A Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial. Diabetes Care. 2003; 26:(6)1879-1882 https://doi.org/10.2337/diacare.26.6.1879

Schwartz JA, Goss SG, Facchin F Surgical debridement alone does not adequately reduce planktonic bioburden in chronic lower extremity wounds. J Wound Care. 2014; 23:S4-S8 https://doi.org/10.12968/jowc.2014.23.Sup9.S4

Kim PJ, Attinger CE, Bigham T Clinic-based debridement of chronic ulcers has minimal impact on bacteria. Wounds. 2018; 30:(5)114-119

Knight CL. The chronic wound management decision tree: a tool for long-term care nurses. J Wound Ostomy Continence Nurs. 1996; 23:(2)92-99 https://doi.org/10.1097/00152192-199603000-00005

Letourneau S, Jensen L. Impact of a decision tree on chronic wound care. J Wound Ostomy Continence Nurs. 1998; 25:(5)240-247 https://doi.org/10.1097/00152192-199809000-00007

Melchior-MacDougall F, Lander J. Evaluation of a decision tree for management of chronic wounds. J Wound Ostomy Continence Nurs. 1995; 22:(2)81-88 https://doi.org/10.1097/00152192-199503000-

Use of a bacterial fluorescence imaging system to target wound debridement and accelerate healing: a pilot study

02 July 2022

Abstract

Objective:

Optimal wound-bed preparation consists of regular debridement to remove devitalised tissues, reduce bacterial load, and to establish an environment that promotes healing. However, lack of diagnostic information at point-of-care limits effectiveness of debridement.

Method:

This observational case series investigated use of point-of-care fluorescence imaging to detect bacteria (loads >104 CFU/g) and guide wound bed preparation. Lower extremity hard-to-heal wounds were imaged over a 12-week period for bacterial fluorescence and wound area.

Results:

A total of 11 wounds were included in the study. Bacterial fluorescence was present in 10 wounds and persisted, on average, for 3.7 weeks over the course of the study. The presence of red or cyan fluorescent signatures from bacteria correlated with an average increase in wound area of 6.5% per week, indicating stalled or delayed wound healing. Fluorescence imaging information assisted in determining the location and extent of wound debridement, and the selection of dressings and/or antimicrobials. Elimination of bacterial fluorescence signature with targeted debridement and other treatments correlated with an average reduction in wound area of 27.7% per week (p<0.05), indicative of a healing trajectory.

Conclusion:

These results demonstrate that use of fluorescence imaging as part of routine wound care enhances assessment and treatment selection, thus facilitating improved wound healing.

The economic burden of wounds in the US costs Medicare an estimated $28.1 billion to $96.8 billion annually.1,2,3 The associated costs of care and risk for severe complications (such as infection or amputation) increases the longer a wound remains open.4,5 A stall in wound closure may be due to a variety of systemic and local factors, among them high bacterial burden.6 At bacterial loads of 104 colony-forming units (CFU) per gram of tissue, delayed wound healing is observed, and wound status worsens for each additional log increase in bacterial load.7 Wounds with bacterial loads that exceed 106 CFU/g are considered clinically infected.8 The presence of devitalised tissue further impairs wound healing by preventing new tissue from forming, thus creating a nidus for bacterial growth.9

Register now to continue reading

Thank you for visiting Wound Care Professional and reading some of our peer-reviewed resources for wound care professionals. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Access to clinical or professional articles

  • New content and clinical updates each month